Category:Drugs: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
No edit summary
Helen (talk | contribs)
No edit summary
Line 17: Line 17:


{|
{|
|<div class="toccolours mw-collapsible mw-collapsed">[[:Category:Antiplatelet drug | Antiplatelet drugs]]
|<div class="toccolours mw-collapsible mw-collapsed">[[:Category:Antiplatelet drug | Antiplatelet drug]]
<div class="mw-collapsible-content">  
<div class="mw-collapsible-content">  
Platelet aggregation is important in haemostasis  and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.  
Platelet aggregation is important in haemostasis  and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.  

Revision as of 03:54, 5 August 2022

Cardiovascular Drug

Although very diverse, cardiovascular drugs can be broadly classified according to their pharmacological action. Basic details of the major groups, together with lists of the drugs are described as follow:


Antiplatelet drug

Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.

Pages in category "Drugs"

The following 200 pages are in this category, out of 295 total.

(previous page) (next page)
(previous page) (next page)